The relationship between oxidative stress and autoimmunity in Hashimoto's thyroiditis

European Journal of Endocrinology

Volumn 173, Issue 6, 2015, Pages 791-799

  Ates, Ihsan ^a   Yilmaz, Fatma Meric ^a   Altay, Mustafa ^a   Yilmaz, Nisbet ^a   Berker, Dilek ^a   Güler, Serdar ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; ARYLESTERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; THIOL; THYROID PEROXIDASE ANTIBODY; ANTI-THYROGLOBULIN; ARYLDIALKYLPHOSPHATASE; AUTOANTIBODY; CARBOXYLESTERASE; IODIDE PEROXIDASE; PON1 PROTEIN, HUMAN; THIOL DERIVATIVE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; AUTOIMMUNITY; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ECHOGRAPHY; ENZYME BLOOD LEVEL; EUTHYROIDISM; FEMALE; HASHIMOTO DISEASE; HUMAN; HYPOTHYROIDISM; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; OVERT HYPOTHYROID; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; SUBCLINICAL HYPOTHYROIDISM; ASYMPTOMATIC DISEASE; CASE CONTROL STUDY; IMMUNOLOGY; METABOLISM; MIDDLE AGED;

ADULT; ARYLDIALKYLPHOSPHATASE; ASYMPTOMATIC DISEASES; AUTOANTIBODIES; AUTOIMMUNITY; CARBOXYLIC ESTER HYDROLASES; CASE-CONTROL STUDIES; FEMALE; HASHIMOTO DISEASE; HUMANS; HYPOTHYROIDISM; IODIDE PEROXIDASE; MALE; MIDDLE AGED; OXIDATIVE STRESS; SULFHYDRYL COMPOUNDS; THYROTROPIN; THYROXINE;

EID: 84947926129     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-15-0617     Document Type: Article

References (36)

1. Jackson SH, Devadas S, Kwon J, Pinto LA & Williams MS. T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation. Nature Immunology 2004 5 818-827. (doi:10.1038/ni1096)
2. Williams MS & Kwon J. T cell receptor stimulation, reactive oxygen species, and cell signaling. Free Radical Biology & Medicine 2004 37 1144-1151. (doi:10.1016/j.freeradbiomed.2004.05.029)
3. Poncin S, Gerard AC, Boucquey M, Senou M, Calderon PB, Knoops B, Lengele B, Many MC & Colin IM. Oxidative stress in the thyroid gland: from harmlessness to hazard depending on the iodine content. Endocrinology 2008 149 424-433. (doi:10.1210/en.2007-0951)
4. Beckman KB & Ames BN. Endogenous oxidative damage of mtDNA. Mutation Research 1999 424 51-58. (doi:10.1016/S0027-5107(99)00007-X)
5. Evans MD & Cooke MS. Factors contributing to the outcome of oxidative damage to nucleic acids. BioEssays 2004 26 533-542. (doi:10.1002/bies.20027)
6. Santi A, Duarte MM, Moresco RN, Menezes C, Bagatini MD, Schetinger MR & Loro VL. Association between thyroid hormones, lipids and oxidative stress biomarkers in overt hypothyroidism. Clinical Chemistry and Laboratory Medicine 2010 48 1635-1639. (doi:10.1515/CCLM.2010.309)
7. Nanda N, Bobby Z, Hamide A, Koner BC & Sridhar MG. Association between oxidative stress and coronary lipid risk factors in hypothyroid women is independent of body mass index. Metabolism 2007 56 1350-1355. (doi:10.1016/j.metabol.2007.05.015)
8. Carmeli E, Bachar A, Barchad S, Morad M & Merrick J. Antioxidant status in the serum of persons with intellectual disability and hypothyroidism: a pilot study. Research in Developmental Disabilities 2008 29 431-438. (doi:10.1016/j.ridd.2007.08.001)
9. Nanda N, Bobby Z & Hamide A. Oxidative stress and protein glycation in primary hypothyroidism. Male/female difference. Clinical and Experimental Medicine 2008 8 101-108. (doi:10.1007/s10238-008-0164-0)
10. McCord JM. Human disease, free radicals, and the oxidant/antioxidant balance. Clinical Biochemistry 1993 26 351-357. (doi:10.1016/0009-9120(93)90111-I)
11. Perl A. Oxidative stress in the pathology and treatment of systemic lupus erythematosus. Nature Reviews. Rheumatology 2013 9 674-686. (doi:10.1038/nrrheum.2013.147)
12. Grygiel-Gorniak B & Puszczewicz M. Oxidative damage and anti-oxidative therapy in systemic sclerosis. Mediators of Inflammation 2014 2014 389582. (doi:10.1155/2014/389582)
13. Torun AN, Kulaksizoglu S, Kulaksizoglu M, Pamuk BO, Isbilen E & Tutuncu NB. Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism. Clinical Endocrinology 2009 70 469-474. (doi:10.1111/j.1365-2265.2008.03348.x)
14. Yilmaz S, Ozan S, Benzer F & Canatan H. Oxidative damage and antioxidant enzyme activities in experimental hypothyroidism. Cell Biochemistry and Function 2003 21 325-330. (doi:10.1002/cbf.1031)
15. Rostami R, Aghasi MR, Mohammadi A & Nourooz-Zadeh J. Enhanced oxidative stress in Hashimoto's thyroiditis: inter-relationships to biomarkers of thyroid function. Clinical Biochemistry 2013 46 308-312. (doi:10.1016/j.clinbiochem.2012.11.021)
16. Friedewald WT, Levy RI & Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry 1972 18 499-502.
17. Ulas T, Buyukhatipoglu H, Kirhan I, Dal MS, Ulas S, Demir ME, Eren MA, Ucar M, Hazar A, Kurkcuoglu IC et al. Evaluation of oxidative stress parameters and metabolic activities of nurses working day and night shifts. Revista da Escola de Enfermagem da U S P 2013 47 471-476.
18. Ates I, Ozkayar N, Topcuoglu C & Dede F. Relationship between oxidative stress parameters and asymptomatic organ damage in hypertensive patients without diabetes mellitus. Scandinavian Cardiovascular Journal 2015 1-23. (doi:10.3109/14017431.2015. 1060355)
19. Villanueva I, Alva-Sanchez C & Pacheco-Rosado J. The role of thyroid hormones as inductors of oxidative stress and neurodegeneration. Oxidative Medicine and Cellular Longevity 2013 2013 218145. (doi:10.1155/2013/218145)
20. Baser H, Can U, Baser S, Yerlikaya FH, Aslan U & Hidayetoglu BT. Assesment of oxidative status and its association with thyroid autoantibodies in patients with euthyroid autoimmune thyroiditis. Endocrine 2015 48 916-923. (doi:10.1007/s12020-014-0399-3)
21. Wang D, Feng JF, Zeng P, Yang YH, Luo J & Yang YW. Total oxidant/antioxidant status in sera of patients with thyroid cancers. Endocrine-Related Cancer 2011 18 773-782. (doi:10.1530/ERC-11-0230)
22. Bedard K & Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiological Reviews 2007 87 245-313. (doi:10.1152/physrev.00044.2005)
23. Segal BH, Grimm MJ, Khan AN, Han W & Blackwell TS. Regulation of innate immunity by NADPH oxidase. Free Radical Biology & Medicine 2012 53 72-80. (doi:10.1016/j.freeradbiomed.2012.04.022)
24. Colin IM, Poncin S, Leveque P, Gallez B & Gerard AC. Differential regulation of the production of reactive oxygen species in Th1 cytokine-treated thyroid cells. Thyroid 2014 24 441-452. (doi:10.1089/thy.2013.0142)
25. Pereira B, Rosa LF, Safi DA, Bechara EJ & Curi R. Control of superoxide dismutase, catalase and glutathione peroxidase activities in rat lymphoid organs by thyroid hormones. Journal of Endocrinology 1994 140 73-77. (doi:10.1677/joe.0.1400073)
26. Fernandez V & Videla LA. Hepatic glutathione biosynthetic capacity in hyperthyroid rats. Toxicology Letters 1996 89 85-89. (doi:10.1016/S0378-4274(96)03791-5)
27. Reddy VS, Gouroju S, Suchitra MM, Suresh V, Sachan A, Srinivasa Rao PV & Bitla AR. Antioxidant defense in overt and subclinical hypothyroidism. Hormone and Metabolic Research 2013 45 754-758. (doi:10.1055/s-0033-1348262)
28. Guerra LN, Moiguer S, Karner M, de Molina MC, Sreider CM & Burdman JA. Antioxidants in the treatment of Graves disease. IUBMB Life 2001 51 105-109. (doi:10.1080/15216540152122102)
29. Baskol G, Atmaca H, Tanriverdi F, Baskol M, Kocer D & Bayram F. Oxidative stress and enzymatic antioxidant status in patients with hypothyroidism before and after treatment. Experimental and Clinical Endocrinology & Diabetes 2007 115 522-526. (doi:10.1055/s-2007-981457)
30. Cebeci E, Oner FA, Usta M, Yurdakul S & Erguney M. Evaluation of oxidative stress, the activities of paraoxonase and arylesterase in patients with subclinic hypothyroidism. Acta Biomaterialia 2011 82 214-222. (doi:10.231/JIM.0b013e31823581dd)
31. Aviram M, Rosenblat M, Billecke S, Erogul J, Sorenson R, Bisgaier CL, Newton RS & La Du B. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radical Biology & Medicine 1999 26 892-904. (doi:10.1016/S0891-5849(98)00272-X)
32. Requejo R, Hurd TR, Costa NJ & Murphy MP. Cysteine residues exposed on protein surfaces are the dominant intramitochondrial thiol and may protect against oxidative damage. FEBS Journal 2010 277 1465-1480. (doi:10.1111/j.1742-4658.2010.07576.x)
33. Thomas JA, Poland B & Honzatko R. Protein sulfhydryls and their role in the antioxidant function of protein S-thiolation. Archives of Biochemistry and Biophysics 1995 319 1-9. (doi:10.1006/abbi.1995.1261)
34. Pasupathi PL. Free radical activity and antioxidant defense mechanisms in patients with hypothyroidism. Thyroid Science 2008 3 1-6.
35. Yildiz A, Gur M, Demirbag R, Yilmaz R, Akyol S, Aslan M & Erel O. Paraoxonase and arylesterase activities in untreated dipper and non-dipper hypertensive patients. Clinical Biochemistry 2008 41 779-784. (doi:10.1016/j.clinbiochem.2008.02.010)
36. Nivedite Nanda ZBvAH. Oxidative stress in anti thyroperoxidase antibody positive hypothyroid patients. Asian Journal of Biochemistry 2012 7 54-58. (doi:10.3923/ajb.2012.54.58)